{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:23:20Z","timestamp":1792610600741,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19gk0110037"],"award-info":[{"award-number":["JP19gk0110037"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Congenital cytomegalovirus (CMV) infection (cCMV) can cause sensorineural hearing loss and neurodevelopmental disabilities in children. Oral valganciclovir (VGCV) therapy has been reported to improve long-term audiological and neurodevelopmental outcomes in patients with cCMV. The levels of CMV DNA in whole blood have been monitored in previous studies. However, quantitative methods using whole blood have not been standardized. Recently, the plasma viral load has been standardized and widely used in CMV-associated diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>CMV viral loads in whole blood and plasma were serially measured in 24 patients with a confirmatory diagnosis of cCMV during oral VGCV therapy using an in-house real-time PCR assay. Plasma samples were assayed using the Cobas 6800 system (Roche Diagnostics) in addition to an in-house assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Plasma CMV viral loads were remarkably decreased at the end of therapy compared to before therapy. A significant correlation of CMV levels between whole blood and plasma was observed (Spearman\u2019s \u03c1\u2009=\u20090.566). The levels of CMV DNA before therapy were significantly correlated with the period of decreasing the viral loads to below the detection limit, not only in whole blood (Spearman\u2019s \u03c1\u2009=\u20090.901) but also in plasma (Spearman, \u03c1\u2009=\u20090.804). Finally, CMV viral loads between the in-house assay and commercially available standardized assay in 75 plasma samples with positive PCR results for CMV were compared; a significant correlation was observed between the results of both assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There was a significant correlation between the two assays (Spearman, \u03c1\u2009=\u20090.882), suggesting that CMV plasma viral loads measured by the standardized assay are widely used to monitor the levels of CMV DNA in patients with cCMV during oral VGCV therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-07995-6","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T09:04:05Z","timestamp":1674119045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Correlation of cytomegalovirus viral load between whole blood and plasma of congenital cytomegalovirus infection under valganciclovir treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuka","family":"Torii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Kakei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumichi","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsushi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"7995_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13052-017-0358-8","volume":"43","author":"C Marsico","year":"2017","unstructured":"Marsico C, Kimberlin DW. Congenital cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr. 2017;43:38.","journal-title":"Ital J Pediatr"},{"key":"7995_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000118","volume":"1","author":"S Koyano","year":"2011","unstructured":"Koyano S, Inoue N, Oka A, Moriuchi H, Asano K, Ito Y, Yamada H, Yoshikawa T, Suzutani T, Japanese Congenital Cytomegalovirus Study Group. Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open. 2011;1: e000118.","journal-title":"BMJ Open"},{"key":"7995_CR3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/infdis\/jiu263","volume":"210","author":"SA Ross","year":"2014","unstructured":"Ross SA, Ahmed A, Palmer AL, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Fowler KB, et al. Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens. J Infect Dis. 2014;210:1415\u20138.","journal-title":"J Infect Dis"},{"key":"7995_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1056\/NEJMoa1404599","volume":"372","author":"DW Kimberlin","year":"2015","unstructured":"Kimberlin DW, Jester PM, Sanchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015;372:933\u201343.","journal-title":"N Engl J Med"},{"key":"7995_CR5","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1093\/infdis\/jiz493","volume":"221","author":"E Acosta","year":"2020","unstructured":"Acosta E, Bowlin T, Brooks J, Chiang L, Hussein I, Kimberlin D, Kauvar LM, Leavitt R, Prichard M, Whitley R. Advances in the development of therapeutics for cytomegalovirus infections. J Infect Dis. 2020;221:S32\u201344.","journal-title":"J Infect Dis"},{"key":"7995_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/archdischild-2015-309154","volume":"101","author":"E Bilavsky","year":"2016","unstructured":"Bilavsky E, Shahar-Nissan K, Pardo J, Attias J, Amir J. Hearing outcome of infants with congenital cytomegalovirus and hearing impairment. Arch Dis Child. 2016;101:433\u20138.","journal-title":"Arch Dis Child"},{"key":"7995_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcv.2015.01.015","volume":"65","author":"J Kawada","year":"2015","unstructured":"Kawada J, Torii Y, Kawano Y, Suzuki M, Kamiya Y, Kotani T, Kikkawa F, Kimura H, Ito Y. Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening. J Clin Virol. 2015;65:41\u20135.","journal-title":"J Clin Virol"},{"key":"7995_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/ped.13433","volume":"60","author":"S Koyano","year":"2018","unstructured":"Koyano S, Morioka I, Oka A, Moriuchi H, Asano K, Ito Y, Yoshikawa T, Yamada H, Suzutani T, Inoue N. Congenital cytomegalovirus in Japan: more than 2 year follow up of infected newborns. Pediatr Int. 2018;60:57\u201362.","journal-title":"Pediatr Int"},{"key":"7995_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019765","volume":"99","author":"I Morioka","year":"2020","unstructured":"Morioka I, Kakei Y, Omori T, Nozu K, Fujioka K, Yoshikawa T, Moriuchi H, Ito Y, Oka A. Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus disease: study protocol clinical trial (SPIRIT compliant). Medicine. 2020;99: e19765.","journal-title":"Medicine"},{"key":"7995_CR10","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.3390\/jcm11133582","volume":"11","author":"I Morioka","year":"2022","unstructured":"Morioka I, Kakei Y, Omori T, Nozu K, Fujioka K, Takahashi N, Yoshikawa T, Moriuchi H, Ito Y, Oka A. Oral valganciclovir therapy in infants aged \u22642 months with congenital cytomegalovirus disease: a multicenter, single-arm, open-label clinical trial in Japan. J Clin Med. 2022;11:3582.","journal-title":"J Clin Med"},{"key":"7995_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/14737159.2017.1325737","volume":"17","author":"P Ramanan","year":"2017","unstructured":"Ramanan P, Razonable RR. Evaluation of COBAS AmpliPrep\/COBAS TaqMan CMV test for use in hematopoietic stem cell transplant recipients. Expert Rev Mol Diagn. 2017;17:633\u20139.","journal-title":"Expert Rev Mol Diagn"},{"key":"7995_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx143","volume":"4","author":"MV Dioverti","year":"2017","unstructured":"Dioverti MV, Lahr BD, Germer JJ, Yao JD, Gartner ML, Razonable RR. Comparison of standardized cytomegalovirus (CMV) viral load thresholds in whole blood and plasma of solid organ and hematopoietic stem cell transplant recipients with CMV infection and disease. Open Forum Infect Dis. 2017;4: ofx143.","journal-title":"Open Forum Infect Dis"},{"key":"7995_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238062","volume":"15","author":"T Lazzarotto","year":"2020","unstructured":"Lazzarotto T, Chiereghin A, Piralla A, Gibertoni D, Piccirilli G, Turello G, Campanini G, Gabrielli L, Costa C, Comai G, et al. Kinetics of cytomegalovirus and Epstein\u2013Barr virus DNA in whole blood and plasma of kidney transplant recipients: implications on management strategies. PLoS ONE. 2020;15: e0238062.","journal-title":"PLoS ONE"},{"key":"7995_CR14","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.bbmt.2018.03.005","volume":"24","author":"T Lazzarotto","year":"2018","unstructured":"Lazzarotto T, Chiereghin A, Piralla A, Piccirilli G, Girello A, Campanini G, Gabrielli L, Costa C, Prete A, Bonifazi F, et al. Cytomegalovirus and Epstein\u2013Barr virus DNA kinetics in whole blood and plasma of allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2018;24:1699\u2013706.","journal-title":"Biol Blood Marrow Transplant"},{"key":"7995_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.534268","volume":"8","author":"M Malagola","year":"2020","unstructured":"Malagola M, Pollara C, Polverelli N, Zollner T, Bettoni D, Gandolfi L, Gramegna D, Morello E, Turra A, Corbellini S, et al. Advances in CMV management: a single center real-life experience. Front Cell Dev Biol. 2020;8: 534268.","journal-title":"Front Cell Dev Biol"},{"key":"7995_CR16","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1128\/JCM.01515-06","volume":"45","author":"K Wada","year":"2007","unstructured":"Wada K, Kubota N, Ito Y, Yagasaki H, Kato K, Yoshikawa T, Ono Y, Ando H, Fujimoto Y, Kiuchi T, et al. Simultaneous quantification of Epstein\u2013Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol. 2007;45:1426\u201332.","journal-title":"J Clin Microbiol"},{"key":"7995_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.104816","volume":"138","author":"J Roh","year":"2021","unstructured":"Roh J, Kim S, Kwak E, Park J, Park Y. Performance evaluation of the Roche cobas 6800 system for quantifying cytomegalovirus DNA in plasma and urine samples. J Clin Virol. 2021;138: 104816.","journal-title":"J Clin Virol"},{"key":"7995_CR18","first-page":"294","volume-title":"Red book: 2021 report of the committee on infectious diseases","author":"American Academy of Pediatrics","year":"2021","unstructured":"American Academy of Pediatrics. Cytomegalovirus infection. In: Kimberlin SW, Barnett ED, Lynfield R, Sawyer MH, editors. Red book: 2021 report of the committee on infectious diseases. Ithaca: American Academy of Pediatrics; 2021. p. 294\u2013300."},{"key":"7995_CR19","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/infdis\/jiy695","volume":"219","author":"C Marsico","year":"2019","unstructured":"Marsico C, Aban I, Kuo H, James SH, Sanchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, et al. Blood viral load in symptomatic congenital cytomegalovirus infection. J Infect Dis. 2019;219:1398\u2013406.","journal-title":"J Infect Dis"},{"key":"7995_CR20","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1128\/JCM.03435-14","volume":"53","author":"NE Babady","year":"2015","unstructured":"Babady NE, Cheng C, Cumberbatch E, Stiles J, Papanicolaou G, Tang YW. Monitoring of cytomegalovirus viral loads by two molecular assays in whole-blood and plasma samples from hematopoietic stem cell transplant recipients. J Clin Microbiol. 2015;53:1252\u20137.","journal-title":"J Clin Microbiol"},{"key":"7995_CR21","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/00007890-200203270-00025","volume":"73","author":"RR Razonable","year":"2002","unstructured":"Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M, Smith TF, Paya CV. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation. 2002;73:968\u201373.","journal-title":"Transplantation"},{"key":"7995_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/jmg.27.9.569","volume":"27","author":"KS Ross","year":"1990","unstructured":"Ross KS, Haites NE, Kelly KF. Repeated freezing and thawing of peripheral blood and DNA in suspension: effects on DNA yield and integrity. J Med Genet. 1990;27:569.","journal-title":"J Med Genet"},{"key":"7995_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jpeds.2005.01.059","volume":"146","author":"SB Boppana","year":"2005","unstructured":"Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, Britt WJ. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr. 2005;146:817\u201323.","journal-title":"J Pediatr"},{"key":"7995_CR24","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1542\/peds.2005-0629","volume":"117","author":"M Lanari","year":"2006","unstructured":"Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B, Landini MP, Faldella G. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics. 2006;117:e76\u201383.","journal-title":"Pediatrics"},{"key":"7995_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/INF.0b013e3181979a27","volume":"28","author":"SA Ross","year":"2009","unstructured":"Ross SA, Novak Z, Fowler KB, Arora N, Britt WJ, Boppana SB. Cytomegalovirus blood viral load and hearing loss in young children with congenital infection. Pediatr Infect Dis J. 2009;28:588\u201392.","journal-title":"Pediatr Infect Dis J"},{"key":"7995_CR26","doi-asserted-by":"publisher","first-page":"F280","DOI":"10.1136\/adc.2007.119230","volume":"93","author":"S Walter","year":"2008","unstructured":"Walter S, Atkinson C, Sharland M, Rice P, Raglan E, Emery VC, Griffiths PD. Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch Dis Child Fetal Neonatal Ed. 2008;93:F280\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"7995_CR27","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1093\/infdis\/jiz601","volume":"221","author":"RR Razonable","year":"2020","unstructured":"Razonable RR, Inoue N, Pinninti SG, Boppana SB, Lazzarotto T, Gabrielli L, Simonazzi G, Pellett PE, Schmid DS. Clinical diagnostic testing for human cytomegalovirus infections. J Infect Dis. 2020;221:S74\u201385.","journal-title":"J Infect Dis"},{"key":"7995_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1600-6143.2008.02513.x","volume":"9","author":"XL Pang","year":"2009","unstructured":"Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaitis JK. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant. 2009;9:258\u201368.","journal-title":"Am J Transplant"},{"key":"7995_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.biologicals.2016.04.005","volume":"44","author":"JF Fryer","year":"2016","unstructured":"Fryer JF, Heath AB, Minor PD. A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology. Biologicals. 2016;44:242\u201351.","journal-title":"Biologicals"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-07995-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-07995-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-07995-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T09:04:27Z","timestamp":1674119067000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-07995-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7995"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-07995-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"assertion":[{"value":"16 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the parents or legal guardians of all participants. The clinical trial study was approved by the ethics committee of each hospital (Kobe University Hospital: approval number 190025, October 23, 2019; The University of Tokyo Hospital: approval number 2019031-11DX, December 24, 2019; Nihon University Itabashi Hospital: approval number 3112-1550, December 27, 2019; Fujita Medical University Hospital: approval number D-15, December 27, 2019; Nagoya University Hospital: approval number 312010, January 21, 2020; and Nagasaki University Hospital: approval number I19-004; January 29, 2020) and registered in the Japan Registry of Clinical Trials (identifier: jRCT2051190075). The study comparing the results from plasma samples was approved by the institutional review board of Nagoya University Graduate School of Medicine (permission number: 040411664). This study was carried out in compliance with the Declaration of Helsinki guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}